1. Home
  2. ICG vs ICCC Comparison

ICG vs ICCC Comparison

Compare ICG & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intchains Group Limited

ICG

Intchains Group Limited

SELL

Current Price

$1.43

Market Cap

81.4M

Sector

Technology

ML Signal

SELL

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

SELL

Current Price

$11.49

Market Cap

88.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ICG
ICCC
Founded
2017
1982
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.4M
88.9M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
ICG
ICCC
Price
$1.43
$11.49
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $2.00
N/A
AVG Volume (30 Days)
★ 282.3K
6.6K
Earning Date
11-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 53.85
EPS
N/A
★ 0.51
Revenue
N/A
★ $26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
$109.44
N/A
P/E Ratio
★ $6.80
$21.08
Revenue Growth
N/A
★ 51.64
52 Week Low
$0.60
$4.52
52 Week High
$2.28
$12.10

Technical Indicators

Market Signals
Indicator
ICG
ICCC
Relative Strength Index (RSI) 59.34 69.65
Support Level $1.41 $9.47
Resistance Level $1.52 $12.10
Average True Range (ATR) 0.08 0.35
MACD -0.01 0.09
Stochastic Oscillator 75.00 100.00

Price Performance

Historical Comparison
ICG
ICCC

About ICG Intchains Group Limited

Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: